[1]
“TREATMENT OUTCOMES OF PACLITAXEL–CARBOPLATIN–BEVACIZUMAB FOR RECURRENT OR METASTATIC EPITHELIAL OVARIAN CANCER AT NGHE AN ONCOLOGY HOSPITAL”, YHCĐ, vol. 67, no. Số CĐ12- Bệnh viện Ung bướu Nghệ An, Aug. 2026, doi: 10.52163/yhc.v67iCD12.6150.